-
CCHIO 2024丨Dr. Shaoli Song: Innovative Strategies for Prostate Cancer Diagnosis and Treatment—The Increasing Value of PSMA-Targeted Therapy
Oncology Frontier: What are the characteristics of PSMA-targeted nuclear imaging techniques, and why are they widely used in prostate cancer management? Dr. Shaoli Song: Prostate-specific membrane antigen (PSMA), also known…
-
AASLD 2024丨Artificial Intelligence Enhancing Early Diagnosis of Metabolic Associated Steatotic Liver Disease
Unveiling the Diagnostic Gap Dr. Ariana Stuart, lead author and researcher from the Washington University School of Medicine, emphasized the urgency of addressing the diagnostic blind spots in MASLD management.…
-
Chinese Expertise at AASLD 2024: Dr. Huiguo Ding’s Team Advances Non-Invasive Differentiation of PSVD and Cirrhotic Portal Hypertension Using Machine
Cirrhosis is the primary cause of portal hypertension (PH), but 15-20% of PH cases stem from non-cirrhotic conditions, notably idiopathic non-cirrhotic portal hypertension (INCPH). INCPH is now categorized under the…
-
The 9th Congress of the CCIHPBA | Prof. Chaoliu Dai: Revisiting Hemorrhage Control and Residual Liver Function Protection in Hepatectomy
At the recent The 9th Congress of the Chinese Chapter of the International Hepato-Pancreato-Biliary Association (CCIHPBA), Prof. Chaoliu Dai from Shengjing Hospital of China Medical University presented on “Controlling Intraoperative Hemorrhage and Protecting Residual Liver Function in Hepatectomy.” Oncology frontier invited Prof. Dai to delve further into this topic and share insights from his presentation.
-
2024 CACA Integrated Gastric Cancer Conference | Prof. Changqing Jing: Insights into Perioperative Immunotherapy for Gastric Cancer
The clinical use of immune checkpoint inhibitors (ICIs) offers a promising approach for locally advanced gastric and gastroesophageal junction (GEJ) cancers, potentially improving cure rates. Recent clinical trials have demonstrated that ICIs combined with chemotherapy, chemoradiotherapy, anti-HER2, or anti-VEGF agents exhibit synergistic and complementary effects. Compared to chemotherapy alone, these combinations show improved pathologic complete…
-
CCHIO 2024丨Dr. Lin Shen: Key Elements and Challenges in Precision Cancer Therapy
From November 14 to 17, 2024, the highly anticipated 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Xi’an. The event, hosted by the China Anti-Cancer Association and co-organized by the Shaanxi Anti-Cancer Association and the Institute for Development Strategy of Holistic Integrative Medicine , gathered leading experts in oncology.At the conference, Oncology…
-
2024 CACA Integrated Lung Cancer Conference | Dr. Gen Lin: Tackling Clinical Challenges, Breaking Through Evidence-Based to Precision Immunotherapy
The 2024 CACA Integrated Lung Cancer Conference, hosted by the Chinese Anti-Cancer Association and the Chinese Anti-Cancer Association’s Integrated Lung Cancer Committee (under preparation), was held in Zhuhai on October 25–26, 2024. With the theme “Uniting Efforts, Leading the Future,” the conference gathered leading domestic experts and scholars in the field of pulmonary tumors for…
-
2024 CACA Integrated Lung Cancer Conference | Dr. Weimin Li: Tailoring Strategies for Lung Nodule Risk Stratification to Empower Precision Lung Cancer
The 2024 CACA Integrated Lung Cancer Conference, hosted by the Chinese Anti-Cancer Association, was held in Zhuhai from October 25 to 26. Focusing on the theme “Gathering Strength, Leading the Future,” the conference brought together prominent experts in the field of lung cancer to discuss critical issues and advancements. Oncology frontier interviewed Dr. Weimin Li…
Connecting Medical Expertise through Media